AHSZX — Alger Health Sciences Fund
Data updated: 2026-06-26
AHSZX — Alger Health Sciences Fund. United States Multi-Cap / All-Cap Growth Health Care Equity · $60.86M AUM. Holdings, fees, performance and SEC filings.
AHSZX Fund Overview
AHSZX — Alger Health Sciences Fund is a US mutual fund managed by Alger Funds, categorised as United States Multi-Cap / All-Cap Growth Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Alger Funds
- Category: United States Multi-Cap / All-Cap Growth Health Care Equity
- Assets under management: $60.86M
- 1-year return: 23.1%
- Ticker: AHSZX
- SEC CIK: 0000003521
- SEC series ID: S000009164
- Share class ID: C000156505
AHSZX Holdings
Top 10 holdings of Alger Health Sciences Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Teva Pharmaceutical Industries Ltd. | 4.58% |
| Impulse Dynamics Ireland | 4.57% |
| Forte Biosciences, Inc. | 4.28% |
| Arrowhead Pharmaceuticals, Inc. | 4.04% |
| Welltower, Inc. | 3.23% |
| Cardinal Health, Inc. | 3.22% |
| Johnson & Johnson | 2.99% |
| Twist Bioscience Corp. | 2.93% |
| Merck & Company, Inc. | 2.88% |
| Nektar Therapeutics | 2.66% |
AHSZX Portfolio Allocation
Asset-class allocation of Alger Health Sciences Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 97.0% |
| Cash & Equivalents | 1.4% |
AHSZX Performance
Total returns for AHSZX (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -0.4% |
| 1 year | 23.1% |
| 3 years (annualised) | 3.8% |
| 5 years (annualised) | 2.2% |
AHSZX Risk Information
Risk metrics for AHSZX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 16.1%
AHSZX Costs and Fees
AHSZX costs about $76 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.76%
- Gross expense ratio: 0.82%
- Portfolio turnover: 289%
- Brokerage commissions: 32.15 bps of average net assets (SEC N-CEN)
AHSZX Cashflows
Over the 12 months to 2026-04, Alger Health Sciences Fund had net outflows of $20.90M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | −$924.72K |
| 2026-03 | −$1.40M |
| 2026-02 | −$826.83K |
| 2026-01 | −$1.63M |
| 2025-12 | −$2.06M |
| 2025-11 | −$910.82K |
AHSZX Debt Constituents
No individual debt constituents are reported in Alger Health Sciences Fund's latest SEC N-PORT filing.
AHSZX Prospectus and SEC Filings
Official Alger Health Sciences Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2025-02-26
- Prospectus supplement (497) — filed 2026-03-05
- Prospectus supplement (497) — filed 2025-03-04
- Portfolio holdings (N-PORT) — filed 2026-06-26
- Portfolio holdings (N-PORT) — filed 2026-03-27
- Portfolio holdings (N-PORT) — filed 2025-12-29
- Annual census (N-CEN) — filed 2026-01-14
- Annual census (N-CEN) — filed 2025-01-13
Related Funds
Other United States Multi-Cap / All-Cap Growth Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.